U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. For Industry
  3. FDA User Fee Programs
  4. Generic Drug User Fee Amendments
  5. Generic Drug Regulatory Science Initiatives Public Meeting: June 21, 2013
  1. Generic Drug User Fee Amendments

Generic Drug Regulatory Science Initiatives Public Meeting: June 21, 2013

The Food and Drug Administration (FDA or the Agency) has scheduled a public meeting on June 21, 2013 to discuss generic drug regulatory science initiatives designed to promote the public health and advance innovation in regulatory decision-making.  The meeting will provide a forum for public discussion of Agency generic drug research priorities and an overview of current efforts.  FDA is seeking input from a variety of stakeholders––industry, academia, patient advocates, professional societies, and others as it develops its annual FY 2014 regulatory science plan.   Additional information on the public meeting is available at:  http://www.gpo.gov/fdsys/pkg/FR-2013-05-09/pdf/2013-11007.pdf.

Back to Top